MedTrace Logo

Safety and Performance of LeadExx LC System in Lead Extraction

NCT02996929 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-12-19

No results posted yet for this study

Summary

The study's main purpose is to evaluate the safety and performance of the LeadExx LC System and its ability to safely extract leads.

The study will enroll 10 patients scheduled for CIED lead extraction. The decision upon lead extraction will be based upon the applicable Heart Rhythm Society guidelines or European Heart Rhythm Association (EHRA).

Conditions

  • Implant Site Infection

Interventions

DEVICE

LC System

Subjects will undergo CIED lead extraction with the LC system

Sponsors & Collaborators

  • LeadExx Cardiac Ltd.

    lead INDUSTRY

Principal Investigators

  • Eyal Nof, Dr. · Sheba Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-28
Primary Completion
2017-02-28
Completion
2017-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02996929 on ClinicalTrials.gov